nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—NISCH—Podofilox—Etoposide—testicular cancer	0.371	0.539	CbGdCrCtD
Naphazoline—NISCH—Vincristine—Vinblastine—testicular cancer	0.317	0.461	CbGdCrCtD
Naphazoline—Ocular discomfort—Methotrexate—testicular cancer	0.0222	0.0711	CcSEcCtD
Naphazoline—Lacrimation—Epirubicin—testicular cancer	0.00801	0.0257	CcSEcCtD
Naphazoline—Lacrimation—Doxorubicin—testicular cancer	0.00741	0.0238	CcSEcCtD
Naphazoline—Keratitis—Epirubicin—testicular cancer	0.00726	0.0233	CcSEcCtD
Naphazoline—Redness—Epirubicin—testicular cancer	0.00698	0.0224	CcSEcCtD
Naphazoline—Keratitis—Doxorubicin—testicular cancer	0.00672	0.0215	CcSEcCtD
Naphazoline—Redness—Doxorubicin—testicular cancer	0.00646	0.0207	CcSEcCtD
Naphazoline—Hyperglycaemia—Ifosfamide—testicular cancer	0.00602	0.0193	CcSEcCtD
Naphazoline—Hypertension—Vinblastine—testicular cancer	0.00556	0.0178	CcSEcCtD
Naphazoline—Erythema—Bleomycin—testicular cancer	0.00544	0.0174	CcSEcCtD
Naphazoline—Discomfort—Vinblastine—testicular cancer	0.00542	0.0174	CcSEcCtD
Naphazoline—Lacrimation increased—Epirubicin—testicular cancer	0.00511	0.0164	CcSEcCtD
Naphazoline—Erythema—Dactinomycin—testicular cancer	0.00508	0.0163	CcSEcCtD
Naphazoline—Eye disorder—Ifosfamide—testicular cancer	0.00499	0.016	CcSEcCtD
Naphazoline—Lacrimation increased—Doxorubicin—testicular cancer	0.00473	0.0152	CcSEcCtD
Naphazoline—Erythema—Ifosfamide—testicular cancer	0.00465	0.0149	CcSEcCtD
Naphazoline—Discomfort—Bleomycin—testicular cancer	0.00458	0.0147	CcSEcCtD
Naphazoline—Vision blurred—Ifosfamide—testicular cancer	0.00438	0.0141	CcSEcCtD
Naphazoline—Eye disorder—Cisplatin—testicular cancer	0.00431	0.0138	CcSEcCtD
Naphazoline—Discomfort—Dactinomycin—testicular cancer	0.00427	0.0137	CcSEcCtD
Naphazoline—Asthenia—Chlorambucil—testicular cancer	0.00412	0.0132	CcSEcCtD
Naphazoline—Hypertension—Ifosfamide—testicular cancer	0.00402	0.0129	CcSEcCtD
Naphazoline—Erythema—Cisplatin—testicular cancer	0.00401	0.0129	CcSEcCtD
Naphazoline—Eye disorder—Etoposide—testicular cancer	0.00394	0.0126	CcSEcCtD
Naphazoline—Discomfort—Ifosfamide—testicular cancer	0.00391	0.0125	CcSEcCtD
Naphazoline—Eye pain—Epirubicin—testicular cancer	0.00379	0.0121	CcSEcCtD
Naphazoline—Vision blurred—Cisplatin—testicular cancer	0.00378	0.0121	CcSEcCtD
Naphazoline—Asthenia—Vinblastine—testicular cancer	0.00377	0.0121	CcSEcCtD
Naphazoline—Hyperhidrosis—Ifosfamide—testicular cancer	0.00367	0.0118	CcSEcCtD
Naphazoline—Eye pain—Doxorubicin—testicular cancer	0.00351	0.0112	CcSEcCtD
Naphazoline—Dizziness—Vinblastine—testicular cancer	0.00348	0.0112	CcSEcCtD
Naphazoline—Nausea—Chlorambucil—testicular cancer	0.00341	0.0109	CcSEcCtD
Naphazoline—Somnolence—Ifosfamide—testicular cancer	0.00338	0.0108	CcSEcCtD
Naphazoline—Discomfort—Cisplatin—testicular cancer	0.00337	0.0108	CcSEcCtD
Naphazoline—Headache—Vinblastine—testicular cancer	0.0033	0.0106	CcSEcCtD
Naphazoline—Asthenia—Bleomycin—testicular cancer	0.00319	0.0102	CcSEcCtD
Naphazoline—Hypertension—Etoposide—testicular cancer	0.00317	0.0102	CcSEcCtD
Naphazoline—Hyperhidrosis—Cisplatin—testicular cancer	0.00316	0.0101	CcSEcCtD
Naphazoline—Nausea—Vinblastine—testicular cancer	0.00312	0.01	CcSEcCtD
Naphazoline—Discomfort—Etoposide—testicular cancer	0.00309	0.00991	CcSEcCtD
Naphazoline—Asthenia—Dactinomycin—testicular cancer	0.00297	0.00953	CcSEcCtD
Naphazoline—Hyperhidrosis—Etoposide—testicular cancer	0.0029	0.00929	CcSEcCtD
Naphazoline—Drowsiness—Methotrexate—testicular cancer	0.00282	0.00903	CcSEcCtD
Naphazoline—Asthenia—Ifosfamide—testicular cancer	0.00272	0.00873	CcSEcCtD
Naphazoline—Sweating—Methotrexate—testicular cancer	0.0027	0.00865	CcSEcCtD
Naphazoline—Hyperglycaemia—Epirubicin—testicular cancer	0.00267	0.00855	CcSEcCtD
Naphazoline—Somnolence—Etoposide—testicular cancer	0.00267	0.00855	CcSEcCtD
Naphazoline—Nausea—Bleomycin—testicular cancer	0.00264	0.00846	CcSEcCtD
Naphazoline—Drowsiness—Epirubicin—testicular cancer	0.00264	0.00845	CcSEcCtD
Naphazoline—Sweating—Epirubicin—testicular cancer	0.00253	0.0081	CcSEcCtD
Naphazoline—Dizziness—Ifosfamide—testicular cancer	0.00251	0.00805	CcSEcCtD
Naphazoline—Hyperglycaemia—Doxorubicin—testicular cancer	0.00247	0.00791	CcSEcCtD
Naphazoline—Nausea—Dactinomycin—testicular cancer	0.00246	0.00789	CcSEcCtD
Naphazoline—Drowsiness—Doxorubicin—testicular cancer	0.00244	0.00782	CcSEcCtD
Naphazoline—Eye disorder—Methotrexate—testicular cancer	0.00236	0.00757	CcSEcCtD
Naphazoline—Asthenia—Cisplatin—testicular cancer	0.00235	0.00753	CcSEcCtD
Naphazoline—Sweating—Doxorubicin—testicular cancer	0.00234	0.00749	CcSEcCtD
Naphazoline—Nausea—Ifosfamide—testicular cancer	0.00226	0.00723	CcSEcCtD
Naphazoline—Eye disorder—Epirubicin—testicular cancer	0.00221	0.00709	CcSEcCtD
Naphazoline—Erythema—Methotrexate—testicular cancer	0.0022	0.00705	CcSEcCtD
Naphazoline—Asthenia—Etoposide—testicular cancer	0.00215	0.0069	CcSEcCtD
Naphazoline—Vision blurred—Methotrexate—testicular cancer	0.00207	0.00665	CcSEcCtD
Naphazoline—Erythema—Epirubicin—testicular cancer	0.00206	0.0066	CcSEcCtD
Naphazoline—Eye disorder—Doxorubicin—testicular cancer	0.00205	0.00656	CcSEcCtD
Naphazoline—Tension—Epirubicin—testicular cancer	0.00202	0.00648	CcSEcCtD
Naphazoline—Nervousness—Epirubicin—testicular cancer	0.002	0.00641	CcSEcCtD
Naphazoline—Dizziness—Etoposide—testicular cancer	0.00198	0.00636	CcSEcCtD
Naphazoline—Nausea—Cisplatin—testicular cancer	0.00194	0.00623	CcSEcCtD
Naphazoline—Vision blurred—Epirubicin—testicular cancer	0.00194	0.00622	CcSEcCtD
Naphazoline—Erythema—Doxorubicin—testicular cancer	0.00191	0.00611	CcSEcCtD
Naphazoline—Headache—Etoposide—testicular cancer	0.00188	0.00602	CcSEcCtD
Naphazoline—Tension—Doxorubicin—testicular cancer	0.00187	0.00599	CcSEcCtD
Naphazoline—Discomfort—Methotrexate—testicular cancer	0.00185	0.00593	CcSEcCtD
Naphazoline—Nervousness—Doxorubicin—testicular cancer	0.00185	0.00593	CcSEcCtD
Naphazoline—Vision blurred—Doxorubicin—testicular cancer	0.0018	0.00576	CcSEcCtD
Naphazoline—Nausea—Etoposide—testicular cancer	0.00178	0.00571	CcSEcCtD
Naphazoline—Hypertension—Epirubicin—testicular cancer	0.00178	0.0057	CcSEcCtD
Naphazoline—Hyperhidrosis—Methotrexate—testicular cancer	0.00174	0.00557	CcSEcCtD
Naphazoline—Discomfort—Epirubicin—testicular cancer	0.00173	0.00555	CcSEcCtD
Naphazoline—Hypertension—Doxorubicin—testicular cancer	0.00165	0.00527	CcSEcCtD
Naphazoline—Hyperhidrosis—Epirubicin—testicular cancer	0.00162	0.00521	CcSEcCtD
Naphazoline—Discomfort—Doxorubicin—testicular cancer	0.0016	0.00514	CcSEcCtD
Naphazoline—Somnolence—Methotrexate—testicular cancer	0.0016	0.00512	CcSEcCtD
Naphazoline—Hyperhidrosis—Doxorubicin—testicular cancer	0.0015	0.00482	CcSEcCtD
Naphazoline—Somnolence—Epirubicin—testicular cancer	0.00149	0.00479	CcSEcCtD
Naphazoline—Somnolence—Doxorubicin—testicular cancer	0.00138	0.00443	CcSEcCtD
Naphazoline—Asthenia—Methotrexate—testicular cancer	0.00129	0.00413	CcSEcCtD
Naphazoline—Asthenia—Epirubicin—testicular cancer	0.00121	0.00387	CcSEcCtD
Naphazoline—Dizziness—Methotrexate—testicular cancer	0.00119	0.00381	CcSEcCtD
Naphazoline—Headache—Methotrexate—testicular cancer	0.00113	0.00361	CcSEcCtD
Naphazoline—Asthenia—Doxorubicin—testicular cancer	0.00112	0.00358	CcSEcCtD
Naphazoline—Dizziness—Epirubicin—testicular cancer	0.00111	0.00356	CcSEcCtD
Naphazoline—Nausea—Methotrexate—testicular cancer	0.00107	0.00342	CcSEcCtD
Naphazoline—Headache—Epirubicin—testicular cancer	0.00105	0.00338	CcSEcCtD
Naphazoline—Dizziness—Doxorubicin—testicular cancer	0.00103	0.0033	CcSEcCtD
Naphazoline—Nausea—Epirubicin—testicular cancer	0.000998	0.0032	CcSEcCtD
Naphazoline—Headache—Doxorubicin—testicular cancer	0.000974	0.00312	CcSEcCtD
Naphazoline—Nausea—Doxorubicin—testicular cancer	0.000924	0.00296	CcSEcCtD
